These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8287632)

  • 1. Azithromycin clinical pharmacokinetics.
    Lalak NJ; Morris DL
    Clin Pharmacokinet; 1993 Nov; 25(5):370-4. PubMed ID: 8287632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of azithromycin and their clinical significance.
    Lode H
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):807-12. PubMed ID: 1662623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of intravenous and oral azithromycin: enhanced tissue activity and minimal drug interactions.
    Rapp RP
    Ann Pharmacother; 1998; 32(7-8):785-93. PubMed ID: 9681095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-directed pharmacokinetics.
    Schentag JJ; Ballow CH
    Am J Med; 1991 Sep; 91(3A):5S-11S. PubMed ID: 1656743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of azithromycin in human serum and tissues.
    Foulds G; Shepard RM; Johnson RB
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():73-82. PubMed ID: 2154441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical pharmacokinetics of azithromycin].
    Singlas E
    Pathol Biol (Paris); 1995 Jun; 43(6):505-11. PubMed ID: 8539072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Azithromycin: tissue pharmacology].
    Bergogne-Bérézin E
    Pathol Biol (Paris); 1995 Jun; 43(6):498-504. PubMed ID: 8539071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azithromycin: the first azalide antibiotic.
    Ballow CH; Amsden GW
    Ann Pharmacother; 1992 Oct; 26(10):1253-61. PubMed ID: 1330097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of lung tissue and hilar lymph node concentrations of azithromycin.
    Cazzola M; Siniscalchi C; Vinciguerra A; Santangelo G; Matera MG; Rossi F
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):88-91. PubMed ID: 8004364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin: mechanisms of action and their relevance for clinical applications.
    Parnham MJ; Erakovic Haber V; Giamarellos-Bourboulis EJ; Perletti G; Verleden GM; Vos R
    Pharmacol Ther; 2014 Aug; 143(2):225-45. PubMed ID: 24631273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new therapeutic approach in the treatment of genital chlamydial infections. Azithromycin (Sumamed)].
    Borisov I
    Akush Ginekol (Sofiia); 1998; 37(3):58-62. PubMed ID: 10204275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absolute bioavailability and intracellular pharmacokinetics of azithromycin in patients with cystic fibrosis.
    Beringer P; Huynh KM; Kriengkauykiat J; Bi L; Hoem N; Louie S; Han E; Nguyen T; Hsu D; Rao PA; Shapiro B; Gill M
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5013-7. PubMed ID: 16304166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous azithromycin.
    Garey KW; Amsden GW
    Ann Pharmacother; 1999 Feb; 33(2):218-28. PubMed ID: 10084418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular surface distribution and pharmacokinetics of a novel ophthalmic 1% azithromycin formulation.
    Akpek EK; Vittitow J; Verhoeven RS; Brubaker K; Amar T; Powell KD; Boyer JL; Crean C
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):433-9. PubMed ID: 19857105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin.
    Lucchi M; Damle B; Fang A; de Caprariis PJ; Mussi A; Sanchez SP; Pasqualetti G; Del Tacca M
    J Antimicrob Chemother; 2008 Apr; 61(4):884-91. PubMed ID: 18252692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azithromycin--spectrum of activity, pharmacokinetics, and clinical applications.
    Drew RH; Gallis HA
    Pharmacotherapy; 1992; 12(3):161-73. PubMed ID: 1319048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between piroxicam and azithromycin during distribution to human periodontal tissues.
    Malizia T; Batoni G; Ghelardi E; Baschiera F; Graziani F; Blandizzi C; Gabriele M; Campa M; Del Tacca M; Senesi S
    J Periodontol; 2001 Sep; 72(9):1151-6. PubMed ID: 11577945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
    Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W
    Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetics of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended-release regimen versus a 3-day immediate-release regimen.
    Liu P; Allaudeen H; Chandra R; Phillips K; Jungnik A; Breen JD; Sharma A
    Antimicrob Agents Chemother; 2007 Jan; 51(1):103-9. PubMed ID: 17060516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug concentration in inflamed periodontal tissues after systemically administered azithromycin.
    Gomi K; Yashima A; Iino F; Kanazashi M; Nagano T; Shibukawa N; Ohshima T; Maeda N; Arai T
    J Periodontol; 2007 May; 78(5):918-23. PubMed ID: 17470027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.